|
Rim Semiconductor Company Files Patent for Breakthrough Technology: related news
Tags:
breakthrough company files patent rim semiconductor technology
PORTLAND, Ore. - Rim Semiconductor Company (OTCBB: RSMI), a company that develops technology for telecommunications service providers, filed a non-provisional patent application on its innovative RQAM™ technology. Rim Semi’s Cup
in IP & Patents
via Earthtimes.org @ 11:01 10th Jul
- Related
July 10, 2008 (FinancialWire) Rim Semiconductor Co. (OTCBB: RSMI) (Current Market Cap. US$356,698.00) filed a non-provisional patent application on its RQAM technology. Rim Semi s Cupria transport processor is based on this RQAM technology, and is able to drive data traffic at more than 40 megabits per second. Existing technologies are able to drive data 15 mbps at this distance on this wire type. The patent, titled Amplitude Modulation Decoder, was filed as a non-provisional patent with the United States Patent and Trademark Office. It was also filed under the Patent Cooperation Treaty. This protects Rim Semi s intellectual property rights across a wide geography. Other companies trading in Rim Semi s industry include ABB Ltd. (NYSE: ABB), Eaton Corp.
in IP & Patents
via Macro World Investor @ 13:13 10th Jul
- Related
PORTLAND, Ore.--(BUSINESS WIRE)--Rim Semiconductor Company (OTCBB: RSMI), a company that develops technology for telecommunications service providers, filed a non-provisional patent application on its innovative RQAM
in IP & Patents
via Business Wire @ 11:01 10th Jul
- Related
PORTLAND, Ore.--(BUSINESS WIRE)--Rim Semiconductor Company (OTCBB: RSMI - News), a company that develops technology for telecommunications service providers, filed a non-provisional patent application on its innovative RQAM
in IP & Patents
via Yahoo! Canada @ 8:40 10th Jul
- Related
Rim Semiconductor Company’s technology, allows data traffic to be processed at 40 megabits per second (Mpbs) 5,500 feet (1.67km) on 26AWG (0.40mm) telephone wire, all thanks to its new Cupria™ transport processor, which is actually based on the soon to be patented RQAM technology.
in IP & Patents
via The Telecom @ 16:08 14th Jul
- Related
July 14, 2008 (FinancialWire) Shares of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) fell after the company said that it lost a challenge in Europe on a key patent which covered certain areas of its gene-silencing technology. Alnylam said claims on the "Glover" patent were overturned by the Opposition Division of the European Patent Office. The patent is licensed from Cancer Research Technology Ltd. and Alnylam said it plans to appeal the decision. Alnylam said that the decision does not alter the position of the company's intellectual property for developing and commercializing RNAi therapeutics, nor does it impact any ongoing business development discussions. The patent is one of 11 held by Alnylam. The goal of gene-silencing, or RNA-based, treatments is to turn off, or silence- the gene at the root of a medical condition, treating the a
in IP & Patents
via Macro World Investor @ 18:40 14th Jul
- Related
announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assignee, Supernus Pharmaceuticals, Inc. The '978 patent covers the Company's approved product, SANCTURA XR(TM), a once-a-day formulation of trospium chloride which is indicated for the treatment of symptoms of an overactive bladder. Based on calculations made by the United States Patent and Trademark Office, the term of the '978 patent is twenty years plus 89 days from its filing date of November 4, 2004, or February 1, 2025. In September 2007, the Company entered into an agreement with Allergan, Inc. by which the Company granted Allergan an exclusive sublicense to market SANCTURA XR in the United States.
in IP & Patents
via Financials.com @ 23:06 13th Aug
- Related
We study how fragmentation of patent rights (patent thickets) and the formation of the Court of Appeal for the Federal Circuit (CAFC) affected the duration of patent disputes, and thus the speed of technology diffusion through licensing. We develop a model of patent litigation which predicts faster settlement agreements when patent rights are fragmented and when there is less uncertainty about court outcomes, as was associated with the pro-patent shift of CAFC. The model also predicts that the impact of fragmentation on settlement duration should be smaller under CAFC. We confirm these predictions empirically using a dataset that covers nearly all patent suits in U.S. federal district courts during the period 1975-2000. Finally, we analyze how fragmentation affects total settlement delay, taking into account both reduction in duration
in IP & Patents
via Centre for Economic Policy Research @ 18:10 1st Sep
- Related
Stocks in the News: Rim Semiconductor Company (OTCBB: RSMI), KLA-Tencor (NASDAQ: KLAC), Teradyne, Inc. (NYSE: TER), Applied Materials, Inc. (NASDAQ: AMAT)
in IP & Patents
via Macro World Investor @ 10:25 11th Jul
- Related
Jul 11, 2008 (M2 PRESSWIRE via COMTEX) -- TER | Quote | Chart | News | PowerRating -- Stocks in the News: Rim Semiconductor Company (OTCBB: RSMI), KLA-Tencor (NASDAQ: KLAC), Teradyne, Inc. (NYSE: TER), Applied Materials, Inc. (NASDAQ: AMAT)
in IP & Patents
via TradingMarkets @ 10:25 11th Jul
- Related
LOS ANGELES--(BUSINESS WIRE)--OriginOil, Inc. (OTCBB:OOIL), the developer of a breakthrough technology to transform algae, the most promising source of renewable oil, into a true competitor to petroleum, has recently deposited an international PCT patent application pursuant to last year's filing of United States patent application 11/829,883 with the United States Patent Office. The international application is related to OriginOil's first patent application to optimize the growth and harvesting of algae cells.
in IP & Patents
via Yahoo! Canada @ 10:21 31st Jul
- Related
Affymetrix, the Santa Clara maker of tools used to study DNA and diagnose diseases, was sued for patent infringement by the Massachusetts Institute of Technology over the company's GeneChip system used to analyze genes. Affymetrix has knowingly infringed the patent, MIT and a company started by an MIT professor said in a federal court complaint filed Tuesday in Boston. Affymetrix filed an application with the U.S. Patent and Trademark Office in September 2004, six months after a similar patent was approved for MIT, the university said in its complaint. The patent regulators ruled in May 2007 that the MIT group was the first inventor, according to the complaint. The GeneChip technology is used to develop new therapeutic drugs and to investigate the cause of cancer, AIDS and other diseases, Affymetrix has said.
in IP & Patents
via SiliconValley.com @ 10:49 3rd Jul
- Related
a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety. The Opposition Division of the European Patent Office, following a three day hearing, announced its decision to revoke European Patent EP 1 230 375, exclusively licensed to Alnylam Pharmaceuticals from Cancer Research Technology, Ltd (UK). The Patent, commonly referred to as the "Glover" patent, broadly relates to medicaments comprising an RNA interference mediating RNA molecule. Opposition briefs to the Glover patent had been filed by Silence Therapeutics AG, Sanofi-Aventis Deutschland GmbH, Quark Biotech, Inc.
in IP & Patents
via Financials.com @ 1:20 13th Jul
- Related
today announced that a patent for its breakthrough multi-codec video compression technology, CodecSys, has been granted by the Mexico patent office. The technology slashes bandwidth requirements for video transmitted over satellite, cable, IP, and wireless media. CodecSys allows, for example, up to twelve HDTV channels to be broadcast over the same media which currently support only two.
in IP & Patents
via Stockwatch @ 9:10 14th Jul
- Related
SALT LAKE CITY - Broadcast International (OTCBB: BCST) (“BI”) today announced that a patent for its breakthrough multi-codec video compression technology, CodecSys, has been granted by the Mexico patent office. The technology sl
in IP & Patents
via Earthtimes.org @ 9:09 14th Jul
- Related
Cargill has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers and develop flavors that make food and beverage products taste better.
in IP & Patents
via Domain-B @ 21:24 25th Jul
- Related
Cargill has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers - such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers - and develop flavors that make food and beverage products taste better.
in IP & Patents
via Genetic Engineering News @ 19:05 23rd Jul
- Related
MINNEAPOLIS - Cargill has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to eff
in IP & Patents
via Earthtimes.org @ 19:04 23rd Jul
- Related
EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.
in IP & Patents
via Nanotechnology News @ 0:59 15th Jul
- Related
ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.
in IP & Patents
via Street Insider @ 14:53 14th Jul
- Related
ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.
in IP & Patents
via Macro World Investor @ 14:53 14th Jul
- Related
ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.
in IP & Patents
via Yahoo! Canada @ 14:53 14th Jul
- Related
We've been covering the ongoing saga of an old patent we've referred to as the "JPEG Patent." This actually isn't the first patent we've called the JPEG Patent, because multiple people claimed to hold patents over the technology that goes into a JPEG image. But, this one was rather special. The patent had been used, repeatedly, by lawyer Ray Niro, against a wide range of opponents, including a patent system critic. The end result was a drawn out review process where all of the original claims were rejected, but a single new claim was added to the patent, which Niro insisted covered JPEGs on a website.
in IP & Patents
via Techdirt @ 22:52 1st Aug
- Related
(RTTNews) - Canada-based technology licensing company Wi-LAN Inc. (WIN.TO: News, Chart, Quote ) Monday said it settled a pending patent litigation against wireless technology company Research In Motion Limited (RIMM: News, Chart, Quote , RIM.TO). Under the settlement, Research In Motion obtained a license to certain patents of Wi-LAN in wireless technology. The company noted that the specific terms of the agreement are confidential.
in IP & Patents
via RTTNews.com @ 13:52 11th Aug
- Related
Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill) CAMARILLO, Calif., Aug. 19 /PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent. The U.S. Patent Office accepted all key aspects of the company's patent application. "We are pleased to receive this Notice of Allowance because it serves to protect the intellectual property and proprietary technology that we have developed," says Stephen Diehl, President and CEO of Surfware.
in IP & Patents
via Reuters @ 22:52 19th Aug
- Related
Search took 0.68 seconds.
|
|